Cellectis Publishes a Scientific Article Unveiling Three
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology ...
Read moreNEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology ...
Read moreDENVER, June 07, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary ...
Read moreGeorge Town, Cayman Islands, April 26, 2024 (GLOBE NEWSWIRE) -- As the crypto art craze sparked by NFTs gained acceptance, ...
Read morePALO ALTO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Reaching a remarkable $2 million USD in top-up fees within a ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.